Why compare Selank and Semax for post-COVID brain fog

Post-COVID brain fog is a persistent cognitive slowdown. Many people experience memory lapses and mental fatigue months after infection. Two nootropic peptides, Selank and Semax, are often discussed as potential aids. Both are synthetic peptides developed in Russia. They share a similar origin but differ in structure and proposed effects. This article compares their profiles for restoring mental clarity.

Brain fog is not a formal diagnosis. It describes a cluster of symptoms like poor concentration and slow thinking. Published research shows that COVID-19 can trigger neuroinflammation. This inflammation may disrupt normal brain function. Peptides like Selank and Semax are studied for their neuroprotective properties. They might influence immune responses and neurotransmitter levels.

Comparing these two compounds requires looking at their mechanisms. Selank is a modified fragment of the immune protein tuftsin. Semax is a fragment of adrenocorticotropic hormone (ACTH). Both are administered as nasal drops or sprays in research. Their effects on cognition have been explored in small human studies. The literature on Selank suggests anti-anxiety benefits. Semax is more often linked to direct cognitive stimulation.

What Selank is and how it works

Selank is a synthetic peptide. It is a heptapeptide, meaning it contains seven amino acids. Its sequence is based on tuftsin, a natural immune system peptide. Tuftsin binds to receptors on immune cells. Selank adds a short tail of amino acids to improve stability. This tail helps the peptide cross the blood-brain barrier.

The blood-brain barrier is a protective filter. It keeps many substances in the blood from entering the brain. Selank can pass through this barrier. Once in the brain, it may affect GABA receptors. GABA is a neurotransmitter that calms neural activity. Selank does not bind to GABA receptors directly. It appears to influence the expression of genes related to GABA signaling.

Published research shows Selank has anxiolytic effects. Anxiolytic means anxiety-reducing. A 2008 study found that Selank reduced anxiety in patients with generalized anxiety disorder. It did not cause sedation or muscle relaxation. This is different from benzodiazepine drugs. Selank also seems to modulate the immune system. It may lower levels of pro-inflammatory cytokines. Cytokines are signaling molecules that can drive inflammation.

For brain fog, this anti-inflammatory action is relevant. Neuroinflammation is a key feature of post-COVID cognitive issues. By calming immune overactivity, Selank might reduce brain fog. It also increases brain-derived neurotrophic factor (BDNF). BDNF supports the survival of existing neurons. It encourages the growth of new neurons and synapses. Higher BDNF levels are associated with better cognitive function.

Selank has been studied for memory and learning. A 2019 trial examined its effects on cognitive performance. The results suggested improved attention and memory in healthy volunteers. The peptide is also used in research on stress-related cognitive decline. Its dual action on anxiety and inflammation makes it a candidate for post-COVID brain fog. However, direct studies on post-COVID brain fog are lacking.

What Semax is and how it works

Semax is also a synthetic peptide. It is a fragment of ACTH, a hormone from the pituitary gland. ACTH normally stimulates the adrenal glands. Semax lacks the hormonal activity of full ACTH. Instead, it retains neuroactive properties. The peptide is modified with a proline-glycine-proline (PGP) tail. This tail also improves stability and brain penetration.

Semax primarily affects the brain's neurotrophic systems. It upregulates BDNF and nerve growth factor (NGF). These proteins promote neuron health and plasticity. Plasticity is the brain's ability to adapt and form new connections. Semax also influences the expression of genes involved in synaptic function. Synapses are the junctions between neurons.

Research on Semax often focuses on cognitive enhancement. A 2010 study showed it improved attention and memory in healthy subjects. It is used in Russia for stroke recovery and cognitive decline. Semax may also have neuroprotective effects. It can reduce oxidative stress and excitotoxicity. Excitotoxicity is damage caused by overactive glutamate receptors.

For post-COVID brain fog, Semax's direct cognitive effects are promising. It might boost mental energy and processing speed. Some research suggests it enhances the brain's default mode network. This network is active during rest and self-referential thought. Disruptions in this network are linked to brain fog. Semax also modulates the immune system. It can lower levels of inflammatory cytokines. This dual action on cognition and inflammation is similar to Selank.

Semax is often described as more stimulating than Selank. Users in online forums report increased focus and alertness. This stimulant-like effect is not accompanied by jitters or anxiety. The peptide's mechanism involves melanocortin receptors. These receptors are part of the brain's stress response system. By acting on them, Semax may improve resilience to mental fatigue.

Head-to-head evidence on cognitive restoration

Direct comparisons between Selank and Semax are rare. No large clinical trial has pitted them against each other for brain fog. Most evidence comes from separate studies and anecdotal reports. A 2022 review of nootropic peptides summarized their distinct profiles. Selank is noted for its calming and anti-anxiety effects. Semax is highlighted for its cognitive-activating properties.

In terms of speed, Semax may work faster for mental clarity. Its stimulant-like effects can be felt within minutes to hours. This is based on user reports and small-scale research. Selank's effects are subtler. They build over days to weeks. The anti-anxiety benefit can indirectly improve cognition. Reduced anxiety often leads to better focus and memory.

For post-COVID brain fog, the choice may depend on symptom profile. If anxiety and stress are prominent, Selank might be more suitable. Its immune-modulating effects could address underlying inflammation. If fatigue and sluggish thinking dominate, Semax might offer quicker relief. Its neurotrophic boost could help repair neural damage.

Both peptides increase BDNF. This is a key factor in cognitive recovery. A 2021 study on BDNF and COVID-19 found that low BDNF levels correlate with persistent symptoms. Raising BDNF might be a therapeutic strategy. Selank and Semax both achieve this through different pathways. Selank does so via GABAergic and immune mechanisms. Semax does so via melanocortin and neurotrophic pathways.

The literature on Selank shows more focus on anxiety and immune balance. The literature on Semax shows more focus on direct cognitive enhancement. Neither has been specifically tested for post-COVID brain fog. Researchers are beginning to explore peptides for this condition. A 2023 pilot study used P21 for reversing cognitive fatigue after overtraining. P21 is another peptide with neurotrophic properties. Such studies may pave the way for Selank and Semax trials.

Where each peptide is studied more

Selank and Semax were developed in Russia. Most clinical research originates from Russian institutions. Semax is approved in Russia as a prescription drug. It is used for cognitive disorders and stroke rehabilitation. Selank is also available as a pharmaceutical in Russia. It is prescribed for anxiety and stress-related conditions.

Outside Russia, research is limited. Both peptides are considered experimental. They are often sold as research chemicals. The regulatory status varies by country. In the United States, they are not FDA-approved for any medical use. This does not stop researchers from studying them. Several animal studies have been conducted in Western labs. These studies confirm the peptides' neuroprotective effects.

Semax has more published studies on cognition. A 2017 trial examined its effects on brain oxygenation. It found that Semax improved cerebral blood flow. This could be beneficial for brain fog caused by reduced oxygen supply. Selank has more studies on anxiety and immunity. A 2015 study explored its antiviral properties. This is interesting because post-COVID brain fog may involve viral persistence.

Both peptides are also studied in combination. Some research suggests they may work synergistically. A 2018 animal study combined Selank and Semax. The combination enhanced memory more than either peptide alone. This hints at a potential dual approach for complex conditions like brain fog. However, human data is absent.

Other nootropic peptides like P21 for reversing cognitive fatigue after overtraining are also being explored. P21 is a small molecule derived from cerebrolysin. It has shown promise in animal models of cognitive impairment. Cerebrolysin itself is a peptide mixture used for dementia and stroke. Dihexa is another experimental compound. It is a small molecule that enhances hepatocyte growth factor. Dihexa is much more potent than BDNF in lab studies. NAD+ is a coenzyme involved in cellular energy. It is not a peptide but is often used for brain fog. These compounds represent the broader landscape of cognitive enhancers.

For post-COVID brain fog, the choice between Selank and Semax remains individual. Research is still catching up to patient needs. The mechanisms of both peptides align with the pathology of brain fog. Neuroinflammation and low BDNF are common targets. Selank may be better for anxiety-dominant brain fog. Semax may be better for fatigue-dominant brain fog. Neither is a proven cure. They are tools that require more rigorous study.

Common questions

Can Selank and Semax be used together for brain fog?

Some research suggests they may be combined. A 2018 animal study found that the combination improved memory more than either peptide alone. However, human data is lacking. The peptides have different mechanisms. Selank is calming, while Semax is stimulating. Using them together might balance their effects. But without clinical trials, the safety and efficacy of this combination are unknown. Researchers advise caution. The interaction between the two peptides has not been fully mapped. Anyone considering them should consult a qualified clinician.

How quickly can someone expect results from these peptides?

Semax is often reported to work within minutes to hours. Its stimulant-like effects on focus and alertness can be rapid. Selank's effects are usually more gradual. They may take days to weeks to become noticeable. This is because Selank works partly by modulating gene expression. Gene expression changes take time. For post-COVID brain fog, the speed of improvement may vary. The underlying cause of the fog matters. If inflammation is the main driver, Selank might take longer but address the root. If neurotransmitter imbalance is key, Semax might offer quicker symptomatic relief.

Are there any side effects associated with Selank or Semax?

Both peptides are generally well-tolerated in studies. Selank has a low side effect profile. It does not cause sedation or withdrawal symptoms. Some users report mild fatigue or headache. Semax can cause overstimulation in some people. This might lead to irritability or insomnia. These effects are usually dose-dependent. Nasal administration can cause local irritation. Long-term safety data is limited. Most studies are short-term. Anyone with a history of seizures or psychiatric conditions should be cautious. The peptides affect brain chemistry in ways that are not fully understood.

How do these peptides compare to other nootropics like P21 or Dihexa?

P21 is a small molecule derived from cerebrolysin. It is designed to enhance neurogenesis. P21 for reversing cognitive fatigue after overtraining is one area of research. Dihexa is a small molecule that binds to hepatocyte growth factor. It is extremely potent in promoting synaptic connections. Both P21 and Dihexa are more experimental than Selank or Semax. They have less human data. Selank and Semax have decades of use in Russia. They are more established in clinical practice. For brain fog, the choice depends on the desired mechanism. P21 and Dihexa are more directly neurotrophic. Selank and Semax have broader immune and stress-modulating effects.

Is there any research on these peptides specifically for post-COVID brain fog?

No direct studies exist yet. The COVID-19 pandemic is recent. Research on long COVID is still emerging. The mechanisms of Selank and Semax align with the known pathology. Neuroinflammation and reduced BDNF are key features. Both peptides address these factors. Some clinicians are using them off-label based on this rationale. But controlled trials are needed. The 2023 pilot study on P21 for cognitive fatigue is a step in this direction. Similar studies for Selank and Semax may follow. Until then, the evidence is indirect.

Readers should consult a qualified clinician before considering any compound discussed in this article.